Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

16 results about "Alcohol intake" patented technology

The recommended safe level of alcohol intake is less than 4 standard drinks per day for men and less than 2 standard drinks per day for women. Alcohol is readily absorbed from the digestive tract, and up to 98% is metabolised in the liver.

Edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as preparation method and application of edible and medicinal composition

The invention discloses an edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as a preparation method and application thereof, and belongs to the technical field of functional foods. The composition consists of the following raw materials in parts by weight: 1-8 parts of ampelopsis grossedentata extract freeze-dried powder, 1-8 parts of astragalus membranaceus extract freeze-dried powder, 1-5 parts of kudzu vine root extract freeze-dried powder, 1-8 parts of hawthorn extract freeze-dried powder and 1-5 parts of cassia seed extract freeze-dried powder. The composition is designed according to a multi-component synergistic interaction principle, and the functions of protecting the liver and dispelling the effects of alcohol are enhanced through targeted interaction of active ingredients such as ampelopsis grossedentata flavone, puerarin and astragaloside; the compound preparation has the compound effects of protecting the liver, dispelling the effects of alcohol, resolving dampness, resisting oxidative stress, regulating lipid metabolism and the like, can remarkably relieve the problems of acute and chronic liver injury and metabolic disorder caused by alcohol intake, and meets the food-grade safety standard and the medicinal activity requirement; the important application prospect is realized in the aspect of preparing a preparation for relieving alcoholic liver injury and improving the liver detoxification function.
Owner:NANJING JIANKE TONGCHUANG BIOTECHNOLOGY CO LTD +1

Application of mannatide in preparation of medicine for treating alcoholic gastric ulcer

The invention belongs to the technical field of biological medicines, and relates to application of mannatide in preparation of a medicine for treating alcoholic gastric ulcer. The mannatide disclosed by the invention can be used for remarkably relieving gastric tissue hemorrhagic lesion and ulcer conditions of alcoholic gastric ulcer for the first time, and the mechanism comprises the following steps: reducing active oxygen generated by alcohol toxicity, and improving oxidative stress of a body by improving antioxidant enzyme activity of the gastric tissue; the inflammatory response of the organism is regulated by regulating and controlling an Akt / NF-kB pathway; a Bax-related apoptosis pathway is inhibited to protect gastric mucosa cells from alcohol-induced apoptosis, so that the integrity of gastric tissue mucosa is protected; the intestinal flora disorder caused by alcohol intake is regulated and controlled, and the acute alcoholic gastric ulcer is prevented by improving the intestinal flora composition of the alcoholic gastric ulcer. The application range of the mannatide is widened, and more solutions are provided for prevention or treatment of acute alcoholic gastric ulcer.
Owner:MICROBIOLOGY INST OF SHAANXI

Pharmaceutical composition for treating alcohol dependence as well as preparation method and application thereof

The invention discloses a pharmaceutical composition for treating alcohol dependence and a preparation method and application thereof. The pharmaceutical composition is prepared from 100 to 1,000 mg of ascorbic acid, 10 to 40 mg of pyrroloquinoline quinone and pharmaceutically acceptable auxiliary materials. According to the pharmaceutical composition provided by the invention, ascorbic acid and pyrroloquinoline quinone are combined for application, so that the alcohol preference rate of mice is remarkably reduced. In a mouse alcohol dependence model, a mouse taking the pharmaceutical composition shows obvious reduction of alcohol intake, and the alcohol dependence is lower. The pharmaceutical composition provided by the invention has the potential of inhibiting alcohol craving and relieving alcohol addiction behaviors, and can effectively intervene in formation and maintenance of alcohol dependence.
Owner:SHENZHEN INST OF ADVANCED TECH